Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
The Journal of Biological Chemistry
|
August 30, 2014
Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch
Wei Tang, Ryan T Strachan, Robert J Lefkowitz, et al.
Journal of Medical Genetics
|
June 27, 1998
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations
D G Evans, L Trueman, A Wallace, et al.
Experimental Physiology
|
February 22, 2002
Hyperprolactinaemia during prolonged exercise in the heat: evidence for a centrally mediated component of fatigue in trained cyclists
Y P Pitsiladis, A T Strachan, I Davidson, et al.
Journal of Medical Genetics
|
August 3, 2000
Autosomal dominant sacral agenesis: Currarino syndrome
S A Lynch, Y Wang, T Strachan, et al.
Journal of Medical Genetics
|
September 2, 2000
Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2
M E Baser, A J Wallace, T Strachan, et al.
Science (New York, N.Y.)
|
December 10, 1982
Molecular drive
G A Dover, T Strachan, E S Coen, et al.
Biochemistry
|
February 9, 2010
p90 Ribosomal S6 kinase 2, a novel GPCR kinase, is required for growth factor-mediated attenuation of GPCR signaling
Ryan T Strachan, John A Allen, Douglas J Sheffler, et al.
Human Genetics
|
May 1, 1995
Eleven novel mutations in the NF2 tumour suppressor gene
D Bourn, G Evans, S Mason, et al.
Human Genetics
|
July 1, 1991
Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families
P J Sinnott, C Costigan, P A Dyer, et al.
Lancet (London, England)
|
November 28, 1987
Prenatal diagnosis of congenital adrenal hyperplasia
T Strachan, P J Sinnott, I Smeaton, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
The Journal of Biological Chemistry
|
August 30, 2014
Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch
Wei Tang, Ryan T Strachan, Robert J Lefkowitz, et al.
Journal of Medical Genetics
|
June 27, 1998
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations
D G Evans, L Trueman, A Wallace, et al.
Experimental Physiology
|
February 22, 2002
Hyperprolactinaemia during prolonged exercise in the heat: evidence for a centrally mediated component of fatigue in trained cyclists
Y P Pitsiladis, A T Strachan, I Davidson, et al.
Journal of Medical Genetics
|
August 3, 2000
Autosomal dominant sacral agenesis: Currarino syndrome
S A Lynch, Y Wang, T Strachan, et al.
Journal of Medical Genetics
|
September 2, 2000
Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2
M E Baser, A J Wallace, T Strachan, et al.
Science (New York, N.Y.)
|
December 10, 1982
Molecular drive
G A Dover, T Strachan, E S Coen, et al.
Biochemistry
|
February 9, 2010
p90 Ribosomal S6 kinase 2, a novel GPCR kinase, is required for growth factor-mediated attenuation of GPCR signaling
Ryan T Strachan, John A Allen, Douglas J Sheffler, et al.
Human Genetics
|
May 1, 1995
Eleven novel mutations in the NF2 tumour suppressor gene
D Bourn, G Evans, S Mason, et al.
Human Genetics
|
July 1, 1991
Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families
P J Sinnott, C Costigan, P A Dyer, et al.
Lancet (London, England)
|
November 28, 1987
Prenatal diagnosis of congenital adrenal hyperplasia
T Strachan, P J Sinnott, I Smeaton, et al.
Page
of 14